M&T Bank
GMAB icon

M&T Bank’s Genmab GMAB Stock Holding History

M&T Bank’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$204K Sell
7,600
-1,531
-17% -$45.9K ﹤0.01% 1555
2025
Q4 		$281K Buy
9,131
+1,170
+15% +$36.5K ﹤0.01% 1428
2025
Q3 		$244K Buy
+7,961
New +$194K ﹤0.01% 1302
2024
Q1 		– Sell
-15,432
Closed -$492K – 1637
2023
Q4 		$492K Buy
15,432
+7,213
+88% +$226K ﹤0.01% 1132
2023
Q3 		$290K Buy
8,219
+1,043
+15% +$39.7K ﹤0.01% 1287
2023
Q2 		$272K Buy
7,176
+312
+5% +$12.4K ﹤0.01% 1345
2023
Q1 		$259K Buy
6,864
+1,274
+23% +$49K ﹤0.01% 1363
2022
Q4 		$237K Buy
+5,590
New +$230K ﹤0.01% 1403
2021
Q3 		– Sell
-5,400
Closed -$220K – 1585
2021
Q2 		$220K Buy
+5,400
New +$208K ﹤0.01% 1420
2021
Q1 		– Sell
-6,259
Closed -$254K – 1622
2020
Q4 		$254K Buy
6,259
+308
+5% +$11.5K ﹤0.01% 1400
2020
Q3 		$218K Sell
5,951
-651
-10% -$23.5K ﹤0.01% 1382
2020
Q2 		$224K Sell
6,602
-5,808
-47% -$158K ﹤0.01% 1328
2020
Q1 		$262K Buy
12,410
+1,975
+19% +$44K ﹤0.01% 1197
2019
Q4 		$233K Buy
+10,435
New +$228K ﹤0.01% 1197

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

M&T Bank's GMAB Position: Q1 2026 in Review

M&T Bank reduced its Genmab (GMAB) stake by 17% in Q1 2026, selling an estimated $45.9K and leaving 7,600 shares worth $204K. The position accounts for ﹤0.01% of the portfolio, ranked #1555.

M&T Bank first reported a position in GMAB in Q4 2019 and has held it in 14 quarters since. The position peaked at $492K in Q4 2023. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • M&T Bank held 7,600 shares of Genmab worth $204K as of Q1 2026.
  • M&T Bank sold 1,531 Genmab shares in Q1 2026, an estimated $45.9K.
  • Genmab made up ﹤0.01% of M&T Bank's portfolio in Q1 2026, its #1555 holding.
  • M&T Bank first reported a position in Genmab in Q4 2019 and has held it in 14 quarters since.
  • M&T Bank's Genmab position peaked at $492K in Q4 2023.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.